B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 5 260 KRW 2.14%
Market Cap: ₩324.2B

Multiples-Based Value

The Multiples-Based Value of one BioPlus Co Ltd stock under the Base Case scenario is 7 424.43 KRW. Compared to the current market price of 5 260 KRW, BioPlus Co Ltd is Undervalued by 29%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Multiples-Based Value
Base Case
7 424.43 KRW
Undervaluation 29%
Multiples-Based Value
Price ₩5 260
B
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
BioPlus Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
BioPlus Co Ltd
KOSDAQ:099430
323.7B KRW 3.3 20.2 9.3 10.7
JP
Hoya Corp
TSE:7741
10T JPY 10.9 39.8 28.9 34.7
CH
Alcon AG
SIX:ALC
29.7B CHF 3.6 38.4 14.8 28.7
US
Medline Inc
NASDAQ:MDLN
37B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
94.9B DKK 3.5 24.6 13 15.5
US
Align Technology Inc
NASDAQ:ALGN
12.4B USD 3.1 30.1 12.9 17.8
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.5 34.6 12 18.7
JP
Asahi Intecc Co Ltd
TSE:7747
937.4B JPY 7.2 53 25.1 34.2
CA
Bausch + Lomb Corp
NYSE:BLCO
5.8B USD 1.1 -16.2 17.2 55.7
CN
Intco Medical Technology Co Ltd
SZSE:300677
37.2B CNY 3.8 21.9 32.4 32.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
36.5B CNY 8 22.1 19.8 19.8
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett